Publication | Closed Access

Gelatinases-stimuli nanoparticles encapsulating 5-fluorouridine and 5-aza-2′-deoxycytidine enhance the sensitivity of gastric cancer cells to chemical therapeutics

NanomedicineGastric Cancer CellsOncologyNanotherapeuticsTherapeutic NanomaterialsMedicineCancer Cell BiologyDrug Delivery SystemsGelatinases-stimuli Nanoparticles5-Aza-2′-deoxycytidine EnhanceTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyCancer Research